Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MG1-MAGEA3 |
Synonyms | |
Therapy Description |
MG1-MAGEA3 is a cancer vaccine comprising an oncolytic Maraba virus strain expressing MAGEA3, which may result in enhanced immune response against cells expressing the tumor-associated antigen (TAA) MAGEA3 (PMID: 30546947). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MG1-MAGEA3 | MG1-MAGEA3 is a cancer vaccine comprising an oncolytic Maraba virus strain expressing MAGEA3, which may result in enhanced immune response against cells expressing the tumor-associated antigen (TAA) MAGEA3 (PMID: 30546947). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|